Envista (NYSE: NVST) insider transactions
In the twelve months to 10 November 2026, executives and directors of Envista reported 3 open-market sales of 17,675 shares ($510,250) and 0 open-market purchases, by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 November 2026 | Keel Paul A | Chairman and CEO | Shares withheld for tax | −54,197 | $23.51 | 497,107 | Form 4 |
| 25 August 2026 | Hammes Eric D. | Chief Financial Officer | Shares withheld for tax | −10,885 | $27.47 | 99,913 | Form 4 |
| 25 August 2026 | Befidi Robert | President, Diagnostics | Shares withheld for tax | −5,147 | $27.47 | 45,785 | Form 4 |
| 25 August 2026 | Nilsson Stefan | President, Nobel Biocare | Shares withheld for tax | −804 | $27.47 | 61,560 | Form 4 |
| 25 August 2026 | Acurio Veronica | President, Orthodontics | Shares withheld for tax | −7,710 | $27.47 | 48,806 | Form 4 |
| 20 August 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Open-market sale, 10b5-1 plan | −8,000 | $27.50 | 27,321 | Form 4 |
| 18 August 2026 | Keel Paul A | Chief Executive Officer | Grant or award | +179,730 | — | 551,304 | Form 4 |
| 25 May 2026 | Keel Paul A | Chief Executive Officer | Shares withheld for tax | −12,811 | $23.43 | 371,574 | Form 4 |
| 19 May 2026 | Tsingos Christine A | Director | Grant or award | +9,330 | — | 59,930 | Form 4 |
| 19 May 2026 | Raskas Daniel | Director | Grant or award | +9,330 | — | 54,010 | Form 4 |
| 19 May 2026 | Gallahue Kieran | Director | Grant or award | +9,330 | — | 54,010 | Form 4 |
| 19 May 2026 | Huennekens R Scott | Director | Grant or award | +12,585 | — | 82,105 | Form 4 |
| 19 May 2026 | Jain Vivek | Director | Grant or award | +9,330 | — | 52,945 | Form 4 |
| 19 May 2026 | Carruthers Wendy | Director | Grant or award | +9,330 | — | 59,940 | Form 4 |
| 19 May 2026 | Pierce James Andrew | Director | Grant or award | +9,330 | — | 18,485 | Form 4 |
| 25 February 2026 | Hammes Eric D. | Chief Financial Officer | Shares withheld for tax | −2,045 | $29.59 | 94,743 | Form 4 |
| 25 February 2026 | Hammes Eric D. | Chief Financial Officer | Grant or award | +16,055 | — | 110,798 | Form 4 |
| 25 February 2026 | Keel Paul A | Chief Executive Officer | Shares withheld for tax | −11,840 | $29.59 | 335,715 | Form 4 |
| 25 February 2026 | Keel Paul A | Chief Executive Officer | Grant or award | +48,670 | — | 384,385 | Form 4 |
| 25 February 2026 | Nance Mark E | General Counsel | Shares withheld for tax | −3,368 | $29.59 | 68,577 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Envista page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.